IT202000000634A1 - Estratti di semi d’uva per uso nella prevenzione o riduzione dello stress - Google Patents

Estratti di semi d’uva per uso nella prevenzione o riduzione dello stress

Info

Publication number
IT202000000634A1
IT202000000634A1 IT102020000000634A IT202000000634A IT202000000634A1 IT 202000000634 A1 IT202000000634 A1 IT 202000000634A1 IT 102020000000634 A IT102020000000634 A IT 102020000000634A IT 202000000634 A IT202000000634 A IT 202000000634A IT 202000000634 A1 IT202000000634 A1 IT 202000000634A1
Authority
IT
Italy
Prior art keywords
extracts
prevention
stress
reduction
grape seeds
Prior art date
Application number
IT102020000000634A
Other languages
English (en)
Inventor
Antonella Riva
Massimo Ronchi
Giovanna Petrangolini
Paolo Morazzoni
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Priority to IT102020000000634A priority Critical patent/IT202000000634A1/it
Priority to CN202180008988.4A priority patent/CN114929254A/zh
Priority to US17/758,701 priority patent/US20230077072A1/en
Priority to EP21704939.4A priority patent/EP4090346A1/en
Priority to AU2021207374A priority patent/AU2021207374A1/en
Priority to CA3164708A priority patent/CA3164708A1/en
Priority to PCT/IB2021/050238 priority patent/WO2021144721A1/en
Priority to JP2022542915A priority patent/JP2023510000A/ja
Priority to BR112022013446A priority patent/BR112022013446A2/pt
Publication of IT202000000634A1 publication Critical patent/IT202000000634A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IT102020000000634A 2020-01-15 2020-01-15 Estratti di semi d’uva per uso nella prevenzione o riduzione dello stress IT202000000634A1 (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT102020000000634A IT202000000634A1 (it) 2020-01-15 2020-01-15 Estratti di semi d’uva per uso nella prevenzione o riduzione dello stress
CN202180008988.4A CN114929254A (zh) 2020-01-15 2021-01-14 用于预防或减轻压力的葡萄籽提取物
US17/758,701 US20230077072A1 (en) 2020-01-15 2021-01-14 Grape seed extracts for use in the prevention or reduction of stress
EP21704939.4A EP4090346A1 (en) 2020-01-15 2021-01-14 Grape seed extracts for use in the prevention or reduction of stress
AU2021207374A AU2021207374A1 (en) 2020-01-15 2021-01-14 Grape seed extracts for use in the prevention or reduction of stress
CA3164708A CA3164708A1 (en) 2020-01-15 2021-01-14 Grape seed extracts for use in the prevention or reduction of stress
PCT/IB2021/050238 WO2021144721A1 (en) 2020-01-15 2021-01-14 Grape seed extracts for use in the prevention or reduction of stress
JP2022542915A JP2023510000A (ja) 2020-01-15 2021-01-14 ストレスの予防または軽減に使用するためのブドウ種子抽出物
BR112022013446A BR112022013446A2 (pt) 2020-01-15 2021-01-14 Extratos de semente de uva para uso na prevenção ou redução de estresse

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102020000000634A IT202000000634A1 (it) 2020-01-15 2020-01-15 Estratti di semi d’uva per uso nella prevenzione o riduzione dello stress

Publications (1)

Publication Number Publication Date
IT202000000634A1 true IT202000000634A1 (it) 2021-07-15

Family

ID=70295761

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102020000000634A IT202000000634A1 (it) 2020-01-15 2020-01-15 Estratti di semi d’uva per uso nella prevenzione o riduzione dello stress

Country Status (9)

Country Link
US (1) US20230077072A1 (it)
EP (1) EP4090346A1 (it)
JP (1) JP2023510000A (it)
CN (1) CN114929254A (it)
AU (1) AU2021207374A1 (it)
BR (1) BR112022013446A2 (it)
CA (1) CA3164708A1 (it)
IT (1) IT202000000634A1 (it)
WO (1) WO2021144721A1 (it)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2315616C1 (ru) * 2006-03-31 2008-01-27 Юрий Анатольевич Верхоланцев Средство для лечения и профилактики сердечно-сосудистых заболеваний
WO2016020853A1 (en) 2014-08-08 2016-02-11 Rottapharm Biotech S.R.L. Purified cocoa beans and grape seeds extracts, production and use thereof for the treatment of central and peripheric human diseases
WO2016020855A1 (en) 2014-08-08 2016-02-11 Rottapharm Biotech S.R.L. Purified grape seeds extracts, production and use thereof for the treatment of central and peripheric human diseases
CN105918864A (zh) 2016-04-28 2016-09-07 合肥珠光粮油贸易有限公司 一种缓解疲劳发酵米糠营养保健米及其制备方法
CN108125013A (zh) 2018-02-06 2018-06-08 大连丹特生物技术有限公司 一种中药戒烟口香糖及其制备方法
CN108936151A (zh) 2018-06-04 2018-12-07 天津商业大学 一种黑果枸杞复合抗焦虑助眠饮品及其制备方法
WO2019046660A1 (en) * 2017-08-30 2019-03-07 Shawn Talbott NUTRITIONAL COMPONENTS AFFECTING THE BALANCE OF THE INTESTINE-BRAIN AXIS AND MENTAL WELFARE

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2315616C1 (ru) * 2006-03-31 2008-01-27 Юрий Анатольевич Верхоланцев Средство для лечения и профилактики сердечно-сосудистых заболеваний
WO2016020853A1 (en) 2014-08-08 2016-02-11 Rottapharm Biotech S.R.L. Purified cocoa beans and grape seeds extracts, production and use thereof for the treatment of central and peripheric human diseases
WO2016020855A1 (en) 2014-08-08 2016-02-11 Rottapharm Biotech S.R.L. Purified grape seeds extracts, production and use thereof for the treatment of central and peripheric human diseases
CN105918864A (zh) 2016-04-28 2016-09-07 合肥珠光粮油贸易有限公司 一种缓解疲劳发酵米糠营养保健米及其制备方法
WO2019046660A1 (en) * 2017-08-30 2019-03-07 Shawn Talbott NUTRITIONAL COMPONENTS AFFECTING THE BALANCE OF THE INTESTINE-BRAIN AXIS AND MENTAL WELFARE
CN108125013A (zh) 2018-02-06 2018-06-08 大连丹特生物技术有限公司 一种中药戒烟口香糖及其制备方法
CN108936151A (zh) 2018-06-04 2018-12-07 天津商业大学 一种黑果枸杞复合抗焦虑助眠饮品及其制备方法

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
ALREFIE Z., INT. J. VITAMIN. NUTR. RES., vol. 85, no. 5-6, 2015, pages 282 - 291
DATABASE WPI Week 200816, Derwent World Patents Index; AN 2008-C15943, XP002800171 *
FLIEGE ET AL., PSYCHOSOM MEAN., vol. 67, no. 1, January 2005 (2005-01-01), pages 78 - 88
GIANNI BELCARO ET AL: "Grape Seed Procyanidins in Pre- and Mild Hypertension: A Registry Study", EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, vol. 2013, 1 January 2013 (2013-01-01), US, pages 1 - 5, XP055726331, ISSN: 1741-427X, DOI: 10.1155/2013/313142 *
REMINGTON: "The Science and practice ofPharmacy", 2013, PHARMACEUTICAL PRESS
TERAUCHI M., MENOPAUSE: THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIET, vol. 21, no. 9, 2014, pages 990 - 996
VOGELS N., EUROPEAN JOURNAL OF CLINICAL NUTRITION, vol. 58, 2004, pages 667 - 673
ZIGMOND AS ET AL., ACTA PHYCHYATR. SCAN, vol. 67, no. 14, 1983, pages 117 - 126

Also Published As

Publication number Publication date
WO2021144721A1 (en) 2021-07-22
BR112022013446A2 (pt) 2022-09-13
JP2023510000A (ja) 2023-03-10
AU2021207374A1 (en) 2022-09-01
US20230077072A1 (en) 2023-03-09
CA3164708A1 (en) 2021-07-22
EP4090346A1 (en) 2022-11-23
CN114929254A (zh) 2022-08-19

Similar Documents

Publication Publication Date Title
CL2022000922A1 (es) Aminas bicíclicas como inhibidores de la cdk2.
IT201600068623A1 (it) “use of a lignin fraction as an anti-phytopathogenic agent and anti-phytopathogenic compositions comprising the same” / “uso di una frazione di lignina come agente antifitopatogenico e composizioni antifitopatogeniche che la comprendono”
EP3765005A4 (en) INHIBITORS OF INTEGRIN ALPHA 2 BETA 1 AND METHOD OF USE
EP3902542A4 (en) CYCLIN-7 DEPENDENT KINASE INHIBITORS AND THEIR USES
EP3761945A4 (en) STORAGE OF PERSONAL CARE COMPOSITIONS
IL287908A (en) A compound used as a kinase inhibitor and its use
IT201900021564A1 (it) Composizione nutraceutica o farmaceutica comprendente ferro pirofosfato per l’uso nel trattamento e/o nella prevenzione di condizioni o patologie caratterizzate da carenza di ferro
IT201700025666A1 (it) Composizione per l’uso nel trattamento dell’ipercolesterolemia e nella prevenzione di patologie cardiovascolari.
IT202000000634A1 (it) Estratti di semi d’uva per uso nella prevenzione o riduzione dello stress
IT201700085412A1 (it) Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
SG11202113330VA (en) Bicyclic compound as rip-1 kinase inhibitor and application thereof
SG11202104207TA (en) Oligosaccharide compositions and methods of use thereof
EP3826623A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANCER CHARACTERIZED BY PCSK9 EXPRESSION
IT201700111939A1 (it) Composizione farmaceutica per l’uso nel trattamento di stati infiammatori
ZA202100402B (en) Emulsion-based personal care compositions and methods for the same
EP3946642A4 (en) SUNSCREEN PRODUCTS AND METHODS OF USE THEREOF
DE112020000415A5 (de) Optoelektronisches halbleiterbauelement und dessen herstellungsverfahren
EP3965776A4 (en) OLIGOSACCHARID COMPOSITIONS AND METHODS OF USE
IT201800002359A1 (it) “composizione ad attivita’ immunomodulatoria e relativo kit per uso nel trattamento e nella prevenzione dell’onicomicosi"
IT201700084318A1 (it) “dispositivo anti-deragliamento per ante scorrevoli di mobili”
BR112021016655A2 (pt) Composição cosmética resistente à água e uso da composição cosmética resistente à água
IT201900021333A1 (it) Impianto per l’assemblaggio di sedie e metodo di assemblaggio implementato tramite tale impianto
IT201800003035A1 (it) Trattamento cosmetico per il miglioramento dell’aspetto estetico e delle caratteristiche fisico-meccaniche delle cheratine tramite l’uso di “pinze molecolari” sulfo-carbossilate.
IT201900000517U1 (it) Conglomerato per la realizzazione di elementi di arredo, relativi manufatti trasparenti e procedimento per la loro realizzazione
IT201900020748A1 (it) Composizione anidra per smalti per unghie e metodo per trattare le unghie con la composizione di smalto